Seroprevalence of Hepatitis E in HIV Positive Patients in Basque Country in 2016 (VIhVhEpb)

Completed

• Conditions: HIV; Hepatitis E

• Registration Number: NCT02847507
• Lead Sponsor: Centre Hospitalier de la côte Basque

Brief Summary

Study of seroprevalence of hepatitis E among HIV positive patient in Basque country, France in 2016.

Detailed Description

Study of seroprevalence of hepatitis E among patient followed and treated in "centre Hospitalier de la Côte Basque" for HIV infections. Study of acquisition of hepatitis E , and determination of liver status using fibrotest in co-infected patients with hepatis C and / or B.

Study Timeline

• Study Start: 2016-07
• Study First Submitted: 2016-07-20
• Study First Submitted QC: 2016-07-27
• Study First Posted: 2016-07-28
• Primary Completion: 2018-01-31
• Study Completion: 2018-01-31
• Status Verified: 2018-07
• Last Update Submitted: 2018-07-16
• Last Update Posted: 2018-07-17

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 307

Inclusion Criteria

• HIV positive > 18

Exclusion Criteria

• patient refusal for participation

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Prevalence of immunoglobulin M (IgM) and Immunoglobulin G (IgG) for hepatitis E in blood sample of each patients. Positive sample for both IgM and IgG will be confirmed using polymerase chain reaction (PCR) techniques	6 months time period	Blood samples will be tested for specific immunoglobulins against hepatitis E virus

Secondary Outcome Measures

Name	Time	Method
fibrotest score	6 months time period	patients infected with hepatitis B or hepatitis C viruses will have their liver status determined using fibrotest score.

Trial Locations

Locations (1)

Centre hospitalier de la Côte Basque; 🇫🇷 Bayonne, France